To further verify the anti-tumor effect of miR-27ai+ sorafenib induced cell apoptosis, we examinedthe level of caspase-3 activity, a hallmark of apoptosis, on both cell lines using Elisa assay. This evidence concerns the gene CASP3 and neoplasm.